TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/14/20 17:31 | 5/14/20 | RMTI | Rockwell Medical, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ellison Russell H | NJ | DO | See Rema | P | 4 | 2.08 | 0 | 2 | 20 | 12 | D | ||||||||||||||
5/28/14 17:30 | 5/27/14 | VTUS | Ventrus Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Ellison Russell H | NY | DO | CEO | P.d | 12 | 0.9200 | 0 | 13 | 29 | 58 | D | ||||||||||||||
5/27/14 09:25 | 5/22/14 | VTUS | Ventrus Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Ellison Russell H | NY | DO | CEO | P.dm | 18 | 0.9052 | 0 | 20 | 80 | 45 | D | ||||||||||||||
5/22/14 16:36 | 5/21/14 | VTUS | Ventrus Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Ellison Russell H | NY | DO | CEO | P.d | 9 | 0.8698 | 0 | 10 | 67 | 25 | D | ||||||||||||||
2/6/13 16:08 | 2/4/13 | VTUS | Ventrus Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Ellison Russell H | NY | DO | CEO | P.dm | 38 | 2.55 | 0 | 15 | New | 15 | D | ||||||||||||||
4/1/10 20:29 | 3/30/10 | CRMD | Cormedix Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ellison Russell H | NJ | D | P.d | 0 | 0.00 | 0 | 160 | New | 160 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |